MDxHealth Gets CLIA OK for Lab | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDxHealth today said that it has received CLIA certification for its laboratory in Irvine, Calif.

The Liege, Belgium-based firm also said that the lab has passed inspection by the California Department of Health and is now fully licensed and operational.

MDxHealth plans to offer epigenetic diagnostic products for a number of cancer indications. Its first assay, Prostate ConfirmMDx will be launched in the first half of this year, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.